发明名称 iRNA AGENT TARGETING VEGF
摘要 <P>PROBLEM TO BE SOLVED: To provide compounds, compositions, and methods useful for modulating the expression of VEGF. <P>SOLUTION: There are provided the compounds, compositions, and methods useful for modulating the expression of vascular endothelial growth factor (VEGF), such as by the mechanism of RNA interference (RNAi). The compositions include iRNA agents that can be unmodified or chemically-modified. The present invention also relates to the use of siRNA targeting VEGF sequences to treat conditions or disorders related to unwanted expression of VEGF, e.g., age-related macular degeneration or diabetic retinopathy. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011188866(A) 申请公布日期 2011.09.29
申请号 JP20110121050 申请日期 2011.05.30
申请人 ALNYLAM PHARMACEUTICALS INC 发明人 DE FOUGEROLLES ANTONIN;FRANK-KAMENETSKI MARIA;MANOHARAN MUTHIAH;RAJEEV KALLANTHOTTAHIL G;HADWIGER PHILLIPP
分类号 C12N15/113;A61K9/00;A61K31/7088;A61K31/7105;A61K31/712;A61K31/7125;A61K35/74;A61K35/76;A61K47/02;A61K47/10;A61K47/12;A61K47/48;A61K48/00;A61P9/10;A61P11/00;A61P11/06;A61P17/06;A61P19/02;A61P27/02;A61P29/00;A61P35/00;A61P35/04;A61P37/06 主分类号 C12N15/113
代理机构 代理人
主权项
地址